There has long been a need to systematize the extragastric manifestations of gastritis, similar to the extraesophageal manifestations of gastroesophageal reflux disease. In this descriptive review, the authors attempt to determine the feasibility of grouping extragastric lesions in Helicobacter pylori-associated gastritis, which may be related by etiologic or pathogenetic principles. Particular attention is paid to the impact of comorbidities on the patient’s body, the difficulties of diagnosing coinfections, determining the role of each, and the effectiveness of treatment for numerous extragastric manifestations. Literature sources were selected from PubMed and the Russian Science Citation Index (RSCI). Initially, 164 scientific articles were identified based on titles and abstracts. Thirty-six articles were selected for detailed analysis.
27 September 2026 in South Russian Journal of Therapeutic Practice
The OLGA (Operative Link on Gastritis Assessment) gastric cancer risk stratification system has become widely used. This classification is based on the morphological characteristics of gastric biopsies obtained using the traditional method within the updated Sydney system. Along with OLGA, the Kimura-Takemoto endoscopic classification of atrophic gastritis, which relies on the topographic principle of assessing atrophy of the antral and corpus mucosa, is widely used. The authors of this study developed an updated OLGA classification, which represents an integrated gastric cancer risk assessment system that combines the advantages of both classifications. Furthermore, assessing cumulative risk using the updated OLGA classification will improve the effectiveness of gastric cancer preventive measures.